Document is current
Any future updates will be listed below
-
Authors
Offenberg, Luisa K.
Sommer, Samira T.
Schmidt, Manuela
Kasten, Stefanie
Bockheim, Florian
Gavrilov, Boris
Hunzelar, Carmen
Ikar, Nur
Oberholz, Maja P. S.
Paños-Willuhn, Joana L.
Weltermann, Birgitta
-
Funding
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
- License Information
-
More Information
Article History
Received: 30 June 2021
Accepted: 4 April 2022
First Online: 20 April 2022
Declarations
:
: The DEGS1 survey was consented with the Federal and State Commissioners for Data Protection and had been approved by the Charité-Universitätsmedizin Berlin Ethics Committee in September 2008 (No. EA2/047/08). Participants provided written informed consent before the interview and examination. The GPCare-1 study was approved by the ethical committee of the Medical Faculty of the University of Bonn in June 2020 (No. 215/20). Patients received information on study procedures, confidentiality, anonymity, and were informed that participation was voluntary both verbally and in writing. Thus, no formal written consent was required as the return of the anonymous questionnaire indicated informed consent from the patient for their data to be used in the study. The GPcare-1 study is registered in the German Clinical Trial Register (DRKS00022330). Both studies were conducted in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: The authors declare no conflict of interest.
